Extracorporeal membrane oxygenation for life-threatening asthma refractory to mechanical ventilation: analysis of the Extracorporeal Life Support Organization registry View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-12-06

AUTHORS

Hye Ju Yeo, Dohyung Kim, Doosoo Jeon, Yun Seong Kim, Peter Rycus, Woo Hyun Cho

ABSTRACT

BACKGROUND: The use of extracorporeal membrane oxygenation (ECMO) in cases of near-fatal asthma (NFA) has increased, but the benefits and potential complications of this therapy have yet to be fully investigated. METHODS: Cases were extracted from the Extracorporeal Life Support Organization Registry between March 1992 and March 2016. All patients with a diagnosis of asthma (according to the International Classification of Diseases 9th edition), who also received ECMO, were extracted. Exclusion criteria included patients who underwent multiple courses of ECMO; those who received ECMO for cardiopulmonary resuscitation or cardiac dysfunction; and those with another primary diagnosis, such as sepsis. We analyzed survival to hospital discharge, complications, and clinical factors associated with in-hospital mortality, in patients with severe life-threatening NFA requiring ECMO support. RESULTS: In total 272 patients were included. The mean time spent on ECMO was 176.4 hours. Ventilator settings, including rate, fraction of inspired oxygen (FiO2), peak inspiratory pressure (PIP), and mean airway pressure, significantly improved after ECMO initiation (rate (breaths/min), 19.0 vs. 11.3, p < 0.001; FiO2 (%), 81.2 vs. 48.8, p < 0.001; PIP (cmH2O), 38.2 vs. 25.0, p < 0.001; mean airway pressure (cmH2O): 21.4 vs. 14.2, p < 0.001). In particular, driving pressure was significantly decreased after ECMO support (29.5 vs. 16.8 cmH2O, p < 0.001). The weaning success rate was 86.7%, and the rate of survival to hospital discharge was 83.5%. The total complication rate was 65.1%, with hemorrhagic complications being the most common (28.3%). Other complications included renal (26.8%), cardiovascular (26.1%), mechanical (24.6%), metabolic (22.4%), infection (16.5%), neurologic (4.8%), and limb ischemia (2.6%). Of the hemorrhagic complications, cannulation site hemorrhage was the most common (13.6%). Using multivariate logistic regression analysis, it was found that hemorrhage was associated with increased in-hospital mortality (odds ratio, 2.97; 95% confidence interval, 1.07-8.24; p = 0.036). Hemorrhage-induced death occurred in four patients (1.5%). The most common reason for death was organ failure (37.8%). CONCLUSIONS: ECMO can provide adequate gas exchange and prevent lung injury induced by mechanical ventilation, and may be an effective bridging strategy to avoid aggressive ventilation in refractory NFA. However, careful management is required to avoid complications. More... »

PAGES

297

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13054-017-1886-8

DOI

http://dx.doi.org/10.1186/s13054-017-1886-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1099702168

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29212551


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Asthma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Extracorporeal Membrane Oxygenation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "International Classification of Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Registries", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Respiration, Artificial", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Societies", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Research Institute for Convergence of Biomedical Science and Technology Pusan National University Yangsan Hospital, Yangsan, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.412591.a", 
          "name": [
            "Department of Pulmonology and Critical Care Medicine, Pusan National University Yangsan Hospital, Geumo-ro 20, Beomeo-ri, Mulgeum-eup, Yangsan-si, Gyeongsangnam-do 50612 Republic of Korea", 
            "Research Institute for Convergence of Biomedical Science and Technology Pusan National University Yangsan Hospital, Yangsan, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yeo", 
        "givenName": "Hye Ju", 
        "id": "sg:person.0751232625.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751232625.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.412591.a", 
          "name": [
            "Research Institute for Convergence of Biomedical Science and Technology Pusan National University Yangsan Hospital, Yangsan, Republic of Korea", 
            "Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Dohyung", 
        "id": "sg:person.01323555273.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323555273.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Research Institute for Convergence of Biomedical Science and Technology Pusan National University Yangsan Hospital, Yangsan, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.412591.a", 
          "name": [
            "Department of Pulmonology and Critical Care Medicine, Pusan National University Yangsan Hospital, Geumo-ro 20, Beomeo-ri, Mulgeum-eup, Yangsan-si, Gyeongsangnam-do 50612 Republic of Korea", 
            "Research Institute for Convergence of Biomedical Science and Technology Pusan National University Yangsan Hospital, Yangsan, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jeon", 
        "givenName": "Doosoo", 
        "id": "sg:person.011524207117.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011524207117.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Research Institute for Convergence of Biomedical Science and Technology Pusan National University Yangsan Hospital, Yangsan, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.412591.a", 
          "name": [
            "Department of Pulmonology and Critical Care Medicine, Pusan National University Yangsan Hospital, Geumo-ro 20, Beomeo-ri, Mulgeum-eup, Yangsan-si, Gyeongsangnam-do 50612 Republic of Korea", 
            "Research Institute for Convergence of Biomedical Science and Technology Pusan National University Yangsan Hospital, Yangsan, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Yun Seong", 
        "id": "sg:person.01071550540.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071550540.46"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Extracorporeal Life Support Organization (ELSO), Ann Arbor, MI USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Extracorporeal Life Support Organization (ELSO), Ann Arbor, MI USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rycus", 
        "givenName": "Peter", 
        "id": "sg:person.01335740002.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335740002.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Research Institute for Convergence of Biomedical Science and Technology Pusan National University Yangsan Hospital, Yangsan, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.412591.a", 
          "name": [
            "Department of Pulmonology and Critical Care Medicine, Pusan National University Yangsan Hospital, Geumo-ro 20, Beomeo-ri, Mulgeum-eup, Yangsan-si, Gyeongsangnam-do 50612 Republic of Korea", 
            "Research Institute for Convergence of Biomedical Science and Technology Pusan National University Yangsan Hospital, Yangsan, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cho", 
        "givenName": "Woo Hyun", 
        "id": "sg:person.01165726454.92", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165726454.92"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00134-015-4015-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037316598", 
          "https://doi.org/10.1007/s00134-015-4015-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00134-004-2187-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007100292", 
          "https://doi.org/10.1007/s00134-004-2187-7"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-12-06", 
    "datePublishedReg": "2017-12-06", 
    "description": "BACKGROUND: The use of extracorporeal membrane oxygenation (ECMO) in cases of near-fatal asthma (NFA) has increased, but the benefits and potential complications of this therapy have yet to be fully investigated.\nMETHODS: Cases were extracted from the Extracorporeal Life Support Organization Registry between March 1992 and March 2016. All patients with a diagnosis of asthma (according to the International Classification of Diseases 9th edition), who also received ECMO, were extracted. Exclusion criteria included patients who underwent multiple courses of ECMO; those who received ECMO for cardiopulmonary resuscitation or cardiac dysfunction; and those with another primary diagnosis, such as sepsis. We analyzed survival to hospital discharge, complications, and clinical factors associated with in-hospital mortality, in patients with severe life-threatening NFA requiring ECMO support.\nRESULTS: In total 272 patients were included. The mean time spent on ECMO was 176.4\u00a0hours. Ventilator settings, including rate, fraction of inspired oxygen (FiO2), peak inspiratory pressure (PIP), and mean airway pressure, significantly improved after ECMO initiation (rate (breaths/min), 19.0 vs. 11.3, p\u2009<\u20090.001; FiO2 (%), 81.2 vs. 48.8, p\u2009<\u20090.001; PIP (cmH2O), 38.2 vs. 25.0, p\u2009<\u20090.001; mean airway pressure (cmH2O): 21.4 vs. 14.2, p\u2009<\u20090.001). In particular, driving pressure was significantly decreased after ECMO support (29.5 vs. 16.8 cmH2O, p\u2009<\u20090.001). The weaning success rate was 86.7%, and the rate of survival to hospital discharge was 83.5%. The total complication rate was 65.1%, with hemorrhagic complications being the most common (28.3%). Other complications included renal (26.8%), cardiovascular (26.1%), mechanical (24.6%), metabolic (22.4%), infection (16.5%), neurologic (4.8%), and limb ischemia (2.6%). Of the hemorrhagic complications, cannulation site hemorrhage was the most common (13.6%). Using multivariate logistic regression analysis, it was found that hemorrhage was associated with increased in-hospital mortality (odds ratio, 2.97; 95% confidence interval, 1.07-8.24; p\u2009=\u20090.036). Hemorrhage-induced death occurred in four patients (1.5%). The most common reason for death was organ failure (37.8%).\nCONCLUSIONS: ECMO can provide adequate gas exchange and prevent lung injury induced by mechanical ventilation, and may be an effective bridging strategy to avoid aggressive ventilation in refractory NFA. However, careful management is required to avoid complications.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/s13054-017-1886-8", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1117766", 
        "issn": [
          "1364-8535", 
          "1466-609X"
        ], 
        "name": "Critical Care", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "21"
      }
    ], 
    "keywords": [
      "extracorporeal membrane oxygenation", 
      "near-fatal asthma", 
      "Extracorporeal Life Support Organization registry", 
      "peak inspiratory pressure", 
      "hospital mortality", 
      "ECMO support", 
      "hemorrhagic complications", 
      "hospital discharge", 
      "membrane oxygenation", 
      "mechanical ventilation", 
      "multivariate logistic regression analysis", 
      "effective bridging strategy", 
      "total complication rate", 
      "diagnosis of asthma", 
      "prevents lung injury", 
      "logistic regression analysis", 
      "adequate gas exchange", 
      "rate of survival", 
      "ECMO initiation", 
      "aggressive ventilation", 
      "asthma refractory", 
      "airway pressure", 
      "clinical factors", 
      "complication rate", 
      "limb ischemia", 
      "lung injury", 
      "organ failure", 
      "cardiac dysfunction", 
      "inspiratory pressure", 
      "primary diagnosis", 
      "ventilator settings", 
      "potential complications", 
      "cardiopulmonary resuscitation", 
      "exclusion criteria", 
      "complications", 
      "common reason", 
      "patients", 
      "multiple courses", 
      "mean time", 
      "success rate", 
      "asthma", 
      "hemorrhage", 
      "ventilation", 
      "regression analysis", 
      "registry", 
      "mortality", 
      "diagnosis", 
      "bridging strategy", 
      "oxygenation", 
      "death", 
      "survival", 
      "careful management", 
      "gas exchange", 
      "sepsis", 
      "ischemia", 
      "neurologic", 
      "resuscitation", 
      "dysfunction", 
      "therapy", 
      "injury", 
      "infection", 
      "rate", 
      "discharge", 
      "refractory", 
      "cases", 
      "pressure", 
      "hours", 
      "failure", 
      "initiation", 
      "setting", 
      "course", 
      "management", 
      "factors", 
      "support", 
      "criteria", 
      "benefits", 
      "analysis", 
      "use", 
      "strategies", 
      "reasons", 
      "fraction", 
      "time", 
      "oxygen", 
      "exchange", 
      "Life Support Organization Registry", 
      "Support Organization Registry", 
      "Organization Registry", 
      "severe life-threatening NFA", 
      "life-threatening NFA", 
      "cannulation site hemorrhage", 
      "site hemorrhage", 
      "Hemorrhage-induced death", 
      "refractory NFA", 
      "life-threatening asthma refractory"
    ], 
    "name": "Extracorporeal membrane oxygenation for life-threatening asthma refractory to mechanical ventilation: analysis of the Extracorporeal Life Support Organization registry", 
    "pagination": "297", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1099702168"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13054-017-1886-8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29212551"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13054-017-1886-8", 
      "https://app.dimensions.ai/details/publication/pub.1099702168"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:44", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_753.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/s13054-017-1886-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13054-017-1886-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13054-017-1886-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13054-017-1886-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13054-017-1886-8'


 

This table displays all metadata directly associated to this object as RDF triples.

269 TRIPLES      22 PREDICATES      138 URIs      127 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13054-017-1886-8 schema:about N07a83072422644ee9d6737b60f3e8616
2 N31f48991678d467089ac438c061c2666
3 N42d3a10ea138411b9aed7b761fabd068
4 N49146e1b0cea403fa40d3399728d4cc0
5 N5dcc46d14eb0481faa068452de4a6938
6 N780a1463e4644de3b725e1a69394b21a
7 N7ece0165f6cc4cec8485f5516abed166
8 N85405d75fe834ef489ec8cc1976fe5ff
9 N8a1a668138e24b2391200a327be3b8b0
10 N9c01b4ccf272424ca2f3957e48307322
11 Na498926af00547fabecffb76255eb57e
12 Na772a699eb234fa09ceec6f7ade38ad5
13 Nb071c580e72d455d9040c2a510dd7f74
14 Nd89f1b0cb8e242bc8e06fbea29dba4be
15 Ndfd4cbd6d834453786dd09f27250cb55
16 anzsrc-for:11
17 anzsrc-for:1102
18 anzsrc-for:1103
19 schema:author N0e086b8a656e416686abe8d59d5897d1
20 schema:citation sg:pub.10.1007/s00134-004-2187-7
21 sg:pub.10.1007/s00134-015-4015-7
22 schema:datePublished 2017-12-06
23 schema:datePublishedReg 2017-12-06
24 schema:description BACKGROUND: The use of extracorporeal membrane oxygenation (ECMO) in cases of near-fatal asthma (NFA) has increased, but the benefits and potential complications of this therapy have yet to be fully investigated. METHODS: Cases were extracted from the Extracorporeal Life Support Organization Registry between March 1992 and March 2016. All patients with a diagnosis of asthma (according to the International Classification of Diseases 9th edition), who also received ECMO, were extracted. Exclusion criteria included patients who underwent multiple courses of ECMO; those who received ECMO for cardiopulmonary resuscitation or cardiac dysfunction; and those with another primary diagnosis, such as sepsis. We analyzed survival to hospital discharge, complications, and clinical factors associated with in-hospital mortality, in patients with severe life-threatening NFA requiring ECMO support. RESULTS: In total 272 patients were included. The mean time spent on ECMO was 176.4 hours. Ventilator settings, including rate, fraction of inspired oxygen (FiO<sub>2</sub>), peak inspiratory pressure (PIP), and mean airway pressure, significantly improved after ECMO initiation (rate (breaths/min), 19.0 vs. 11.3, p &lt; 0.001; FiO<sub>2</sub> (%), 81.2 vs. 48.8, p &lt; 0.001; PIP (cmH<sub>2</sub>O), 38.2 vs. 25.0, p &lt; 0.001; mean airway pressure (cmH<sub>2</sub>O): 21.4 vs. 14.2, p &lt; 0.001). In particular, driving pressure was significantly decreased after ECMO support (29.5 vs. 16.8 cmH<sub>2</sub>O, p &lt; 0.001). The weaning success rate was 86.7%, and the rate of survival to hospital discharge was 83.5%. The total complication rate was 65.1%, with hemorrhagic complications being the most common (28.3%). Other complications included renal (26.8%), cardiovascular (26.1%), mechanical (24.6%), metabolic (22.4%), infection (16.5%), neurologic (4.8%), and limb ischemia (2.6%). Of the hemorrhagic complications, cannulation site hemorrhage was the most common (13.6%). Using multivariate logistic regression analysis, it was found that hemorrhage was associated with increased in-hospital mortality (odds ratio, 2.97; 95% confidence interval, 1.07-8.24; p = 0.036). Hemorrhage-induced death occurred in four patients (1.5%). The most common reason for death was organ failure (37.8%). CONCLUSIONS: ECMO can provide adequate gas exchange and prevent lung injury induced by mechanical ventilation, and may be an effective bridging strategy to avoid aggressive ventilation in refractory NFA. However, careful management is required to avoid complications.
25 schema:genre article
26 schema:inLanguage en
27 schema:isAccessibleForFree true
28 schema:isPartOf N65eaf4f886594095a46feb681661cf84
29 Ne2685e591b3d42d88f9b727f7da23046
30 sg:journal.1117766
31 schema:keywords ECMO initiation
32 ECMO support
33 Extracorporeal Life Support Organization registry
34 Hemorrhage-induced death
35 Life Support Organization Registry
36 Organization Registry
37 Support Organization Registry
38 adequate gas exchange
39 aggressive ventilation
40 airway pressure
41 analysis
42 asthma
43 asthma refractory
44 benefits
45 bridging strategy
46 cannulation site hemorrhage
47 cardiac dysfunction
48 cardiopulmonary resuscitation
49 careful management
50 cases
51 clinical factors
52 common reason
53 complication rate
54 complications
55 course
56 criteria
57 death
58 diagnosis
59 diagnosis of asthma
60 discharge
61 dysfunction
62 effective bridging strategy
63 exchange
64 exclusion criteria
65 extracorporeal membrane oxygenation
66 factors
67 failure
68 fraction
69 gas exchange
70 hemorrhage
71 hemorrhagic complications
72 hospital discharge
73 hospital mortality
74 hours
75 infection
76 initiation
77 injury
78 inspiratory pressure
79 ischemia
80 life-threatening NFA
81 life-threatening asthma refractory
82 limb ischemia
83 logistic regression analysis
84 lung injury
85 management
86 mean time
87 mechanical ventilation
88 membrane oxygenation
89 mortality
90 multiple courses
91 multivariate logistic regression analysis
92 near-fatal asthma
93 neurologic
94 organ failure
95 oxygen
96 oxygenation
97 patients
98 peak inspiratory pressure
99 potential complications
100 pressure
101 prevents lung injury
102 primary diagnosis
103 rate
104 rate of survival
105 reasons
106 refractory
107 refractory NFA
108 registry
109 regression analysis
110 resuscitation
111 sepsis
112 setting
113 severe life-threatening NFA
114 site hemorrhage
115 strategies
116 success rate
117 support
118 survival
119 therapy
120 time
121 total complication rate
122 use
123 ventilation
124 ventilator settings
125 schema:name Extracorporeal membrane oxygenation for life-threatening asthma refractory to mechanical ventilation: analysis of the Extracorporeal Life Support Organization registry
126 schema:pagination 297
127 schema:productId N3d6ca9e379584577b5f4aac4fffe5189
128 N4cb6fa3ae4094b46bf85d4a5df383417
129 N685a3eb28b5047099297a27ab2a84249
130 schema:sameAs https://app.dimensions.ai/details/publication/pub.1099702168
131 https://doi.org/10.1186/s13054-017-1886-8
132 schema:sdDatePublished 2022-01-01T18:44
133 schema:sdLicense https://scigraph.springernature.com/explorer/license/
134 schema:sdPublisher N3ae35540de124e56be8c47ba243f11c9
135 schema:url https://doi.org/10.1186/s13054-017-1886-8
136 sgo:license sg:explorer/license/
137 sgo:sdDataset articles
138 rdf:type schema:ScholarlyArticle
139 N07a83072422644ee9d6737b60f3e8616 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Adolescent
141 rdf:type schema:DefinedTerm
142 N0e086b8a656e416686abe8d59d5897d1 rdf:first sg:person.0751232625.11
143 rdf:rest Nb2fd3a383e714c44b6f72ee1e766ccfc
144 N31f48991678d467089ac438c061c2666 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Aged
146 rdf:type schema:DefinedTerm
147 N3ae35540de124e56be8c47ba243f11c9 schema:name Springer Nature - SN SciGraph project
148 rdf:type schema:Organization
149 N3d6ca9e379584577b5f4aac4fffe5189 schema:name doi
150 schema:value 10.1186/s13054-017-1886-8
151 rdf:type schema:PropertyValue
152 N42d3a10ea138411b9aed7b761fabd068 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Asthma
154 rdf:type schema:DefinedTerm
155 N49146e1b0cea403fa40d3399728d4cc0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Adult
157 rdf:type schema:DefinedTerm
158 N4cb6fa3ae4094b46bf85d4a5df383417 schema:name dimensions_id
159 schema:value pub.1099702168
160 rdf:type schema:PropertyValue
161 N5dcc46d14eb0481faa068452de4a6938 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Female
163 rdf:type schema:DefinedTerm
164 N65eaf4f886594095a46feb681661cf84 schema:volumeNumber 21
165 rdf:type schema:PublicationVolume
166 N685a3eb28b5047099297a27ab2a84249 schema:name pubmed_id
167 schema:value 29212551
168 rdf:type schema:PropertyValue
169 N780a1463e4644de3b725e1a69394b21a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name International Classification of Diseases
171 rdf:type schema:DefinedTerm
172 N7ece0165f6cc4cec8485f5516abed166 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Societies
174 rdf:type schema:DefinedTerm
175 N85405d75fe834ef489ec8cc1976fe5ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Middle Aged
177 rdf:type schema:DefinedTerm
178 N8a1a668138e24b2391200a327be3b8b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Aged, 80 and over
180 rdf:type schema:DefinedTerm
181 N935e9dd52eab4e70b2de43aeaed7d724 rdf:first sg:person.01071550540.46
182 rdf:rest Nf68873cc71b841d3821af6908dc8f91d
183 N9c01b4ccf272424ca2f3957e48307322 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Humans
185 rdf:type schema:DefinedTerm
186 Na498926af00547fabecffb76255eb57e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Male
188 rdf:type schema:DefinedTerm
189 Na51287d2414b41bdb7fef4a01f9cb73e rdf:first sg:person.01165726454.92
190 rdf:rest rdf:nil
191 Na772a699eb234fa09ceec6f7ade38ad5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Retrospective Studies
193 rdf:type schema:DefinedTerm
194 Nb071c580e72d455d9040c2a510dd7f74 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Registries
196 rdf:type schema:DefinedTerm
197 Nb2fd3a383e714c44b6f72ee1e766ccfc rdf:first sg:person.01323555273.11
198 rdf:rest Nfa917e37302d401c97ab71dc35010591
199 Nd89f1b0cb8e242bc8e06fbea29dba4be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
200 schema:name Respiration, Artificial
201 rdf:type schema:DefinedTerm
202 Ndfd4cbd6d834453786dd09f27250cb55 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
203 schema:name Extracorporeal Membrane Oxygenation
204 rdf:type schema:DefinedTerm
205 Ne2685e591b3d42d88f9b727f7da23046 schema:issueNumber 1
206 rdf:type schema:PublicationIssue
207 Nf68873cc71b841d3821af6908dc8f91d rdf:first sg:person.01335740002.98
208 rdf:rest Na51287d2414b41bdb7fef4a01f9cb73e
209 Nfa917e37302d401c97ab71dc35010591 rdf:first sg:person.011524207117.99
210 rdf:rest N935e9dd52eab4e70b2de43aeaed7d724
211 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
212 schema:name Medical and Health Sciences
213 rdf:type schema:DefinedTerm
214 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
215 schema:name Cardiorespiratory Medicine and Haematology
216 rdf:type schema:DefinedTerm
217 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
218 schema:name Clinical Sciences
219 rdf:type schema:DefinedTerm
220 sg:journal.1117766 schema:issn 1364-8535
221 1466-609X
222 schema:name Critical Care
223 schema:publisher Springer Nature
224 rdf:type schema:Periodical
225 sg:person.01071550540.46 schema:affiliation grid-institutes:grid.412591.a
226 schema:familyName Kim
227 schema:givenName Yun Seong
228 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01071550540.46
229 rdf:type schema:Person
230 sg:person.011524207117.99 schema:affiliation grid-institutes:grid.412591.a
231 schema:familyName Jeon
232 schema:givenName Doosoo
233 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011524207117.99
234 rdf:type schema:Person
235 sg:person.01165726454.92 schema:affiliation grid-institutes:grid.412591.a
236 schema:familyName Cho
237 schema:givenName Woo Hyun
238 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165726454.92
239 rdf:type schema:Person
240 sg:person.01323555273.11 schema:affiliation grid-institutes:grid.412591.a
241 schema:familyName Kim
242 schema:givenName Dohyung
243 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01323555273.11
244 rdf:type schema:Person
245 sg:person.01335740002.98 schema:affiliation grid-institutes:None
246 schema:familyName Rycus
247 schema:givenName Peter
248 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01335740002.98
249 rdf:type schema:Person
250 sg:person.0751232625.11 schema:affiliation grid-institutes:grid.412591.a
251 schema:familyName Yeo
252 schema:givenName Hye Ju
253 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0751232625.11
254 rdf:type schema:Person
255 sg:pub.10.1007/s00134-004-2187-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007100292
256 https://doi.org/10.1007/s00134-004-2187-7
257 rdf:type schema:CreativeWork
258 sg:pub.10.1007/s00134-015-4015-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037316598
259 https://doi.org/10.1007/s00134-015-4015-7
260 rdf:type schema:CreativeWork
261 grid-institutes:None schema:alternateName Extracorporeal Life Support Organization (ELSO), Ann Arbor, MI USA
262 schema:name Extracorporeal Life Support Organization (ELSO), Ann Arbor, MI USA
263 rdf:type schema:Organization
264 grid-institutes:grid.412591.a schema:alternateName Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea
265 Research Institute for Convergence of Biomedical Science and Technology Pusan National University Yangsan Hospital, Yangsan, Republic of Korea
266 schema:name Department of Pulmonology and Critical Care Medicine, Pusan National University Yangsan Hospital, Geumo-ro 20, Beomeo-ri, Mulgeum-eup, Yangsan-si, Gyeongsangnam-do 50612 Republic of Korea
267 Department of Thoracic and Cardiovascular Surgery, Pusan National University Yangsan Hospital, Yangsan, Republic of Korea
268 Research Institute for Convergence of Biomedical Science and Technology Pusan National University Yangsan Hospital, Yangsan, Republic of Korea
269 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...